Try a new search

Format these results:

Searched for:

in-biosketch:true

person:iosifd01

Total Results:

299


Grant Report on the Transcranial near Infrared Radiation and Cerebral Blood Flow in Depression (TRIADE) Study

Iosifescu, Dan V.; Collins, Katherine A.; Hurtado-Puerto, Aura; Irvin, Molly K.; Clancy, Julie A.; Sparpana, Allison M.; Sullivan, Elizabeth F.; Parincu, Zamfira; Ratai, Eva Maria; Funes, Christopher J.; Weerasekera, Akila; Dmochowski, Jacek P.; Cassano, Paolo
We report on the rationale and design of an ongoing National Institute of Mental Health (NIMH) sponsored R61-R33 project in major depressive disorder (MDD). Current treatments for MDD have significant limitations in efficacy and side effect burden. There is a critical need for device-based treatments in MDD that are efficacious, well-tolerated, and easy to use. This project focuses on the adjunctive use of the transcranial photobiomodulation (tPBM) with near-infrared (NIR) light for the treatment of MDD. tPBM with NIR light penetrates robustly into the cerebral cortex, stimulating the mitochondrial respiratory chain, and also significantly increases cerebral blood flow (CBF). In the R61 phase, we will conduct target engagement studies to demonstrate dose-dependent effects of tPBM on the prefrontal cortex (PFC) CBF, using the increase in fMRI blood-oxygenation-level-dependent (BOLD) signal levels as our Go/No-go target engagement biomarker. In the R33 phase, we will conduct a randomized clinical trial of tPBM vs. sham in MDD to establish the target engagement and evaluate the association between changes in the biomarker (BOLD signal) and changes in clinical symptoms, while also collecting important information on antidepressant effects, safety, and tolerability. The study will be done in parallel at New York University/the Nathan Kline Institute (NYU/NKI) and at Massachusetts General Hospital (MGH). The importance of this study is threefold: 1. it targets MDD, a leading cause of disability worldwide, which lacks adequate treatments; 2. it evaluates tPBM, which has a well-established safety profile and has the potential to be safe in at-home administration; and 3. it uses fMRI BOLD changes as a target engagement biomarker. If effects are confirmed, the present study will both support short-term clinical development of an easy to scale device for the treatment of MDD, while also validating a biomarker for the development of future, novel modulation strategies.
SCOPUS:85146818498
ISSN: 2304-6732
CID: 5423872

Rapidity of Symptom Improvement With Intranasal Esketamine for Major Depressive Disorder: A Systematic Review and Meta-Analysis

Hock, Rebecca S; Feeney, Anna; Iovieno, Nadia; Murrough, James W; Mathew, Sanjay J; Iosifescu, Dan V; Fava, Maurizio; Jha, Manish K; Papakostas, George I
PMID: 36516320
ISSN: 1555-2101
CID: 5382192

Relationships between interoceptive sensibility and resting-state functional connectivity of the insula in obsessive-compulsive disorder

Eng, Goi Khia; Collins, Katherine A; Brown, Carina; Ludlow, Molly; Tobe, Russell H; Iosifescu, Dan V; Stern, Emily R
Patients with obsessive-compulsive disorder (OCD) exhibit abnormality in their subjective perception of internal sensation, a process known as interoceptive sensibility (IS), as well as altered functioning of the insula, a key neural structure for interoception. We investigated the multivariate structure of IS in 77 OCD patients and 53 controls and examined associations of IS with resting-state functional connectivity (FC) of the insula within the OCD group. For each group, principal component analysis was performed on 8 subscales of the Multidimensional Assessment of Interoceptive Awareness assessing putatively "adaptive" and "maladaptive" aspects of IS. Associations between IS components and insula FC in the OCD group were evaluated using seed regions placed in each of 3 subdivisions of the insula (posterior, anterior dorsal, and anterior ventral). Behaviorally, controls showed a 2-component solution broadly categorized into "adaptive" and "maladaptive" IS, while OCD patients exhibited a 3-component solution. The general tendency to notice or be aware of sensation loaded onto an "adaptive" IS component in controls but loaded onto both "adaptive" and "maladaptive" IS components in OCD. Within OCD, insula FC was differentially associated with distinct aspects of IS, identifying network connections that could serve as future targets for the modulation of IS in OCD.
PMID: 35257146
ISSN: 1460-2199
CID: 5183432

Effect of Concomitant Benzodiazepines on the Antidepressant Effects of Ketamine: Findings From the RAPID Intravenous Ketamine Study

Feeney, Anna; Hoeppner, Bettina B; Freeman, Marlene P; Flynn, Martina; Iosifescu, Dan V; Trivedi, Madhukar H; Sanacora, Gerard; Mathew, Sanjay J; DeBattista, Charles; Ionescu, Dawn F; Cusin, Cristina; Papakostas, George I; Jha, Manish K; Fava, Maurizio
PMID: 36383742
ISSN: 1555-2101
CID: 5371612

Adiponectin in anorexia nervosa and its modifiers: A meta-regression study

Tural, Umit; Iosifescu, Dan V
OBJECTIVE:Adiponectin, which is secreted from adipose tissue, is a protein hormone. Although a large body of studies have found that circulating adiponectin levels increase in anorexia nervosa (AN) and caloric restriction, the effect of subtypes of AN and modifiers of adiponectin in AN are not yet known. METHODS:A systematic search of electronic databases was performed using the search terms "adiponectin," "anorexia nervosa," and "eating disorder" up to January 2021. All studies published in peer-reviewed journals, which included cases and control groups, were selected. The main outcome was the pooled standardized mean difference (SMD) in adiponectin levels between cases and controls, using the random-effects model. Modifiers of SMD were tested via meta-regression. Heterogeneity and publication bias were evaluated. RESULTS:Thirty-four studies met all eligibility criteria. The total sample of AN participants (Hedges' g = .765, p < .0001), and specifically the binge-eating/purging (Hedges' g = 1.211, p < .00001) and restrictive subtypes (Hedges' g = .913, p < .00001) of AN have increased adiponectin plasma levels compared with healthy controls. Meta-regression determined that insulin, IGF-1, BMI, triglyceride, resistin, glucose, IL-6 levels are significant modifiers of adiponectin levels. DISCUSSION/CONCLUSIONS:Compared with controls, adiponectin levels are higher in AN overall, and specifically in the binge-eating/purging and the restrictive AN subtypes. Many of metabolic parameters of glucose metabolism and pro-inflammatory molecules modify the relationship between AN and adiponectin levels. Adipose tissue is important to maintain metabolic stability. PUBLIC SIGNIFICANCE/UNASSIGNED:Anorexia nervosa is a psychiatric disorder associated with a severe decrease in body weight and multiple metabolic abnormalities, including an increase in the hormone adiponectin. In this paper, we used meta-analysis, a powerful statistical method, to aggregate data from 34 rigorously selected research reports. This enabled us to understand the value of adiponectin to differentiate clinical subtypes of anorexia nervosa and the relations between adiponectin and other important metabolic parameters.
PMID: 35689560
ISSN: 1098-108x
CID: 5248592

Very Low-Level Transcranial Photobiomodulation for Major Depressive Disorder: The ELATED-3 Multicenter, Randomized, Sham-Controlled Trial

Iosifescu, Dan V; Norton, Richard J; Tural, Umit; Mischoulon, David; Collins, Katherine; McDonald, Erin; De Taboada, Luis; Foster, Simmie; Cusin, Cristina; Yeung, Albert; Clain, Alisabet; Schoenfeld, David; Hamblin, Michael R; Cassano, Paolo
PMID: 35950904
ISSN: 1555-2101
CID: 5287092

The Association of Life Events Outside the Workplace and Burnout: A Cross-Sectional Study on Nursing Assistants

Tortorelli, Mariana; Trigo, Telma Ramos; Bolibio, Renata; de Freitas, Camila Colás Sabino; Ribeiro, Floracy Gomes; de Lucia, Mara Cristina Souza; Iosifescu, Dan V; Fráguas, Renério
BACKGROUND:Burnout, by definition, is related to adverse chronic workplace stressors. Life events outside the workplace have been associated with an increased risk of psychiatric morbidity. However, it is unknown whether life events outside the workplace increase the severity of burnout. PURPOSE/OBJECTIVE:The aim of the study was to investigate the association between burnout and life events outside the workplace in nursing assistants. METHODS:In an observational, cross-sectional, single-site study of 521 nursing assistants at a university hospital, we assessed burnout with the Maslach Burnout Inventory-Human Services Survey, and life events with the Social Readjustment Rating Scale. We constructed equations of multiple linear regression analyses that included each burnout subscale as the dependent variable and a domain of life events as the independent variable. Results were adjusted for potential confounders, including gender, no religion or faith, years of work, and depression. RESULTS:An increase in the number of life events in the domain of personal changes or difficulties (e.g., personal injury or illness, sexual difficulties, change in recreation, church activities, social activities, sleeping habits, eating habits and revision of personal habits) was associated with increased severity of emotional exhaustion. An increase in the number of life events in the domain of changes in familial situation and in the domains of death of relatives or friends were associated with increased severity of depersonalization. Those associations were independent of work-related life events and other potential confounders. CONCLUSIONS:Life events outside the workplace may increase the levels of burnout in nursing assistants.
PMID: 35954702
ISSN: 1660-4601
CID: 5287242

Pharmacogenomic Testing for Next-Step Antidepressant Selection: Still a Work in Progress [Comment]

Iosifescu, Dan V
PMID: 35819435
ISSN: 1538-3598
CID: 5269082

Childhood trauma and treatment outcomes during mood-stabilising treatment with lithium or quetiapine among outpatients with bipolar disorder

Wrobel, Anna L; Köhler-Forsberg, Ole; Sylvia, Louisa G; Russell, Samantha E; Dean, Olivia M; Cotton, Sue M; Thase, Michael; Calabrese, Joseph R; Deckersbach, Thilo; Tohen, Mauricio; Bowden, Charles L; McInnis, Melvin; Kocsis, James H; Friedman, Edward S; Ketter, Terence A; Shelton, Richard C; Ostacher, Michael J; Iosifescu, Dan V; Berk, Michael; Turner, Alyna; Nierenberg, Andrew A
BACKGROUND:Childhood trauma affects the course of mood disorders. Researchers are now considering childhood trauma as an influential factor in the treatment of mood disorders. However, the role of childhood trauma in the treatment of bipolar disorder remains understudied. METHODS:The effect of childhood trauma on treatment outcomes was evaluated among participants randomised to treatment with lithium or quetiapine in the Clinical and Health Outcomes Initiatives in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE) study by clinician assessment. Mixed effects linear regression models were used to analyse rates of improvement in symptom severity (assessed with the Bipolar Inventory of Symptoms Scale and the Clinical Global Impression Scale for Bipolar Disorder) and functional impairment (assessed with the Longitudinal Interval Follow-up Evaluation-Range of Impaired Functioning Tool). RESULTS:A history of any childhood trauma was reported by 52.7% of the sample (N = 476). Although participants with a history of any childhood trauma presented with greater symptom severity and functional impairment at most study visits, participants with and without a history of any childhood trauma showed similar rates of improvement in symptom severity and functional impairment over the 24 weeks of treatment. CONCLUSION/CONCLUSIONS:This is the first study to explore the association between childhood trauma and treatment outcomes during treatment with lithium or quetiapine in the context of a randomised trial. In Bipolar CHOICE, a history of childhood trauma did not inhibit improvement in symptom severity or functional impairment. Nevertheless, these findings need replication across different settings.
PMID: 35243620
ISSN: 1600-0447
CID: 5174722

Efficacy and Safety of AXS-05 (Dextromethorphan-Bupropion) in Patients With Major Depressive Disorder: A Phase 3 Randomized Clinical Trial (GEMINI)

Iosifescu, Dan V; Jones, Amanda; O'Gorman, Cedric; Streicher, Caroline; Feliz, Samantha; Fava, Maurizio; Tabuteau, Herriot
PMID: 35649167
ISSN: 1555-2101
CID: 5282992